Insights & Publications

Pharmaceuticals & Medical Products

Pharma M&A: Agile shouldn’t mean ad hoc

Pharma M&A: Agile shouldn’t mean ad hoc

February 2016—Under pressure to be active acquirers, some pharmaceutical and medical-products companies may be neglecting best practices. Here’s where they can most improve.more

Editor's choice


How healthcare systems can become digital-health leaders

January 2016—The potential of digitization is well understood, yet healthcare systems are struggling to convert ambition into reality. Here’s what we recommend.more

interview | McKinsey Quarterly

Organizing for breakthrough innovation

January 2016—Roche’s CEO talks about its R&D structure, tough decisions, and long-term mind-set.more


How pharma can win in a digital world

December 2015—The digital revolution is well under way for pharma companies. We spoke with 20 leading executives to find out how they cope—and what they do to stay ahead.more


The role of big data in medicine

November 2015—Technology is revolutionizing our understanding and treatment of disease, says the founding director of the Icahn Institute for Genomics and Multiscale Biology at New York’s Mount Sinai Health System.more

  • includes:
Road to digital success_1536x1536_Thumbnail

The road to digital success in pharma

August 2015—Pharmaceutical companies can play a central role in the digital revolution of healthcare. But capturing this opportunity requires identifying the right initiatives.more


Pharma’s next challenge

July 2015—Emerging markets are becoming ever more important for pharma. Yet to be successful, a rapid shift from a marketing and sales focus to an access-driven commercial model must occur.more


Novartis on digitizing medicine in an aging world

June 2015—CEO Joseph Jimenez explains where the company is placing its bets and how it’s seeking to bridge biology with technology.more

  • includes:

Africa: A continent of opportunity for pharma and patients

June 2015—Africa may be the only pharmaceutical market where genuinely high growth is still achievable. Here’s what’s driving that strength and how companies should react.more


Maintaining momentum in Brazil’s pharmaceutical market

April 2015—Despite macroeconomic deceleration, we expect Brazil's pharma market to grow 7–10 percent per year until 2020. Double-digit growth is possible, but will require a granular approach.more

article | McKinsey Quarterly

Japan: Lessons from a hyperaging society

March 2015—The country’s population, already the world’s oldest, is aging quickly. Companies in Europe, North America, and Asia can learn from its experience.more

Capturing the new value segment_1536x1536_Thumbnail

Capturing the new ‘value’ segment in medical devices

January 2015—The growing demand for products that are “good enough” and competitively priced has pushed medical-product manufacturers to develop strategies to attract and retain this new segment of customers.more

Medical-device manufacturers_1536x1536_Thumbnail

How medical-device manufacturers can transform marketing and sales capabilities

January 2015—Device manufacturers experiencing declining growth or narrowing margins may need to reevaluate their commercial models.more

About this content

The material on this page draws on the research and experience of McKinsey consultants and other sources. To learn more about our expertise, please visit the Pharmaceuticals & Medical Products Practice.